Our Team

Biogelx is engaging experienced business professionals and scientist all over the world to be the first in providing solutions for the key issues on the market.


John Waddell


John is a qualified solicitor and has extensive experience of driving value and leading early stage high growth companies to successful exit. In his early career John worked for Christian Salveson where he led more than sixty global M&A transactions, more recently he was CEO of Archangels from 2005 to 2015 where he grew value in their portfolio and led nine profitable exits. John continues to advise Archangels, sits on the boards of four early-stage companies and Northern 3 Venture Capital Trust. With John at the helm, our dedicated team is poised to deliver the next stage of growth.



Chief Executive Officer

Mitch is a charismatic leader, and business growth addict, who has successfully driven the commercialisation for a range of technology and service companies within the life sciences sector. Mitch has worked for large multinationals, SME’s and start-ups including Millipore, Quintiles, Deloitte, Touche, Sartorius Stedim Biotech, Bioprocessors Corporation and Giltech Limited. In his most recent role, Mitch led the commercial team at BioOutsource, a Glasgow based start-up that was founded in 2007. Over 9 years, the company grew from 15 to 180 people and was successfully acquired by Sartorius Stedim Biotech in April 2015.



Founder and Chief Scientific Officer

Rein is a true champion in an area of nanoscience that focuses on creating materials and systems that are inspired by biology. He has won several awards for his work including the 2013 RSC Norman Heatley Prize, 2013 RSC Emerging Technologies Award and 2007 Macro Group UK Young Researchers Medal. Rein is the founding director of the ASRC’s Nanoscience Initiative at CUNY and is also the Einstein Professor of Chemistry at Hunter College. He gained his MSc degree in Biotechnology at the University of Wageningen (NL), PhD in Physical Chemistry at the University of Strathclyde and postdoctoral training at the University of Edinburgh. From 2003-2008 he was in the School of Materials, University of Manchester.




Head of Operations

Mhairi is a technical champion in the biotechnology market with experience in 3D biomaterials based on synthetic peptide hydrogels. As a founding Biogelx employee, Mhairi has vast experience and knowledge of our commercial biomaterials. In her current role at Biogelx, Mhairi utilises her skills and experience of the products to oversee and manage company operations. She holds a PhD in Pure and Applied Chemistry from the University of Strathclyde.



Head of Technical Services

Laura is a passionate and experienced research & development scientist with a broad understanding of the
product development and commercialisation of 3D biomaterials. She is an expert in Biogelx’s range of simple, yet functional peptide hydrogels and their varied applications, and has a natural talent for managing relationships with a wide range of stakeholders within the academic and business sectors. Laura holds a PhD in Organic Chemistry from the University of Strathclyde and has worked in research labs within companies such as Astrazeneca and Syngenta.



Director Strategic Collaborations

Sandy, a qualified pharmacist, brings over 30 years of commercial experience to Biogelx; having worked with several international companies providing both products and services to the biotech community. Sandy has led both operational and multinational commercial teams at several large biotech product and service providers and has a strong track record of delivering on key strategic and collaborative initiatives.



Global Business Development Manager

Elia is a motivated Business Development professional with broad experience in product commercialization within the 3D cell culture space. Elia holds a PhD in Cellular and Molecular Biology from Universidad Autónoma de Madrid and understands the customer needs in a wide-range of biological applications. She spent two years at Biogelx in New York, heading our US office and successfully driving international sales of our innovative peptide hydrogels. In her current role at Biogelx, Elia manages relationships with biotechnology partners and other industry and academic collaborators to develop and grow our business. Her customer-centric nature always helps to find the best solutions for our clients.